AXQ Capital LP lifted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 124.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,260 shares of the medical instruments supplier’s stock after purchasing an additional 46,781 shares during the period. AXQ Capital LP’s holdings in DENTSPLY SIRONA were worth $1,069,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of XRAY. Arizona State Retirement System lifted its holdings in DENTSPLY SIRONA by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock worth $748,000 after buying an additional 807 shares in the last quarter. True Wealth Design LLC raised its position in shares of DENTSPLY SIRONA by 49.7% during the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock worth $45,000 after acquiring an additional 1,181 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in shares of DENTSPLY SIRONA by 5.3% during the third quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after acquiring an additional 1,293 shares during the period. AlphaQuest LLC lifted its stake in shares of DENTSPLY SIRONA by 2.5% during the second quarter. AlphaQuest LLC now owns 52,817 shares of the medical instruments supplier’s stock valued at $839,000 after acquiring an additional 1,294 shares during the period. Finally, Empowered Funds LLC boosted its holdings in DENTSPLY SIRONA by 8.8% in the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 1,320 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on XRAY. Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a report on Thursday, November 6th. Barclays began coverage on shares of DENTSPLY SIRONA in a research note on Monday, December 8th. They set an “underweight” rating and a $12.00 price target for the company. Bank of America raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and raised their price objective for the company from $13.00 to $17.00 in a research note on Thursday, February 19th. JPMorgan Chase & Co. lowered their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Finally, Mizuho increased their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Tuesday, January 20th. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $14.46.
DENTSPLY SIRONA Stock Up 0.1%
NASDAQ:XRAY opened at $12.55 on Tuesday. DENTSPLY SIRONA Inc. has a 1 year low of $9.85 and a 1 year high of $19.27. The stock has a 50-day moving average price of $12.26 and a two-hundred day moving average price of $12.47. The stock has a market cap of $2.50 billion, a price-to-earnings ratio of -2.84, a PEG ratio of 0.99 and a beta of 1.01. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36.
DENTSPLY SIRONA Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 5.1%. The ex-dividend date was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is -14.48%.
Insider Activity
In other news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.52% of the stock is owned by corporate insiders.
DENTSPLY SIRONA Profile
Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.
The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
